News

Emphasis of 'physician preference items' in healthcare distribution

Analysis from Prime Therapeutics points to severe cost hurdles for biosimilars developed and marketed in the US

However, most payers will continue to adjust their drug coverage

Step-by-step process for addressing potential shortages is outlined

Identity Hub expedites access to regulated content in clinical research; now, prescribing and other commercial applications are being adopted

Collaboration with American College of Cardiology could result in new health-outcomes results

Nearly 100 cargo stations have been enhanced for pharma cold-chain distribution

First of what are expected to be many global 3PL sites, especially for specialty pharmaceuticals

$2-billion acquisition brings a $5-billion/yr PBM to Rite Aid's 4,600 retail stores

Vaccine trials will continue without a clear path forward

KoolTemp GTS Instant avoids use--and cost--of refrigerants

Whole blood use is declining while plasma-derived product consumption rises

Annual specialty-distribution study focuses trend in oncology, chronic diseases

More executional capabilities derive from affiliation with parent, inVentiv Health

Company uses online media to promote fill rates by over 50%

$296-million bid makes it the 'stalking horse' buyer in Dendreon auction

Roughly 40% are for rare diseases; PD-1 oncolytics capture industry attention

Mapi Group casts itself as a leading 'health research and commercialization' player

'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney

So long WAG, hello to WBA as pharma manufacturers look at a consolidating buyer landscape

Pharmacists' ranking, continuing a two-year decline, is now neck-and-neck with doctors

Express Scripts touts a 'fundamental change' in drug pricing; others would call it negotiating a discount

Acquisition builds on Dohmen's rare-disease business

Poltraf acquisition adds to a network of 14 facilities serving Eastern and Western Europe

Will formularies become a consumer's concern for healthcare provision?

The broad changes taking place in the pharma supply chain this year are a relevant focus for the annual conference and exhibition

FDA enforcement delay to May 1 isn't slowing down project work